Kevin M. Picardat

Array ( [id] => 1062879 [patent_doc_number] => 06849594 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Purification and use of human recombinant cartilage oligomeric matrix protein' [patent_app_type] => utility [patent_app_number] => 09/606763 [patent_app_country] => US [patent_app_date] => 2000-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13407 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849594.pdf [firstpage_image] =>[orig_patent_app_number] => 09606763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1349725 [patent_doc_number] => 06579968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Compositions and methods for treatment of sexual dysfunction' [patent_app_type] => B1 [patent_app_number] => 09/606501 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6775 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579968.pdf [firstpage_image] =>[orig_patent_app_number] => 09606501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1536369 [patent_doc_number] => 06337317 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Antimicrobial peptides and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/604864 [patent_app_country] => US [patent_app_date] => 2000-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 11973 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337317.pdf [firstpage_image] =>[orig_patent_app_number] => 09604864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609715 [patent_doc_number] => 06998474 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-14 [patent_title] => 'Polypeptides of the “basic helix-loop-helix” bHLH family, corresponding nucleic acid sequences' [patent_app_type] => utility [patent_app_number] => 09/595947 [patent_app_country] => US [patent_app_date] => 2000-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34211 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998474.pdf [firstpage_image] =>[orig_patent_app_number] => 09595947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504073 [patent_doc_number] => 06465429 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Antimicrobial cationic peptides' [patent_app_type] => B1 [patent_app_number] => 09/593321 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 16711 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465429.pdf [firstpage_image] =>[orig_patent_app_number] => 09593321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376458 [patent_doc_number] => 06303373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Method of measuring plasma membrane targeting of GLUT4' [patent_app_type] => 1 [patent_app_number] => 9/591025 [patent_app_country] => US [patent_app_date] => 2000-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 8 [patent_no_of_words] => 18286 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303373.pdf [firstpage_image] =>[orig_patent_app_number] => 591025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548547 [patent_doc_number] => 06346245 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Procedure for extraction and use of hatching fluid from Atlantic salmon' [patent_app_type] => B1 [patent_app_number] => 09/581026 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2141 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346245.pdf [firstpage_image] =>[orig_patent_app_number] => 09581026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 749977 [patent_doc_number] => 07022669 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-04 [patent_title] => 'Echinocandin derivatives, method for preparing same and application as antifungal agents' [patent_app_type] => utility [patent_app_number] => 10/018073 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2423 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022669.pdf [firstpage_image] =>[orig_patent_app_number] => 10018073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411233 [patent_doc_number] => 06528485 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Site-specific preparation of polyethylene glycol-grf conjugates' [patent_app_type] => B1 [patent_app_number] => 09/587460 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 9765 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528485.pdf [firstpage_image] =>[orig_patent_app_number] => 09587460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1298998 [patent_doc_number] => 06623926 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Methods for producing 5-nucleic acid-protein conjugates' [patent_app_type] => B1 [patent_app_number] => 09/585207 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5184 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623926.pdf [firstpage_image] =>[orig_patent_app_number] => 09585207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 833615 [patent_doc_number] => 07396905 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-08 [patent_title] => 'Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto' [patent_app_type] => utility [patent_app_number] => 09/575580 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 33 [patent_no_of_words] => 60580 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396905.pdf [firstpage_image] =>[orig_patent_app_number] => 09575580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1359882 [patent_doc_number] => 06573243 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Pompilid wasp-derived neuropeptides' [patent_app_type] => B1 [patent_app_number] => 09/486283 [patent_app_country] => US [patent_app_date] => 2000-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11670 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573243.pdf [firstpage_image] =>[orig_patent_app_number] => 09486283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 467529 [patent_doc_number] => 07235521 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-06-26 [patent_title] => 'Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins' [patent_app_type] => utility [patent_app_number] => 09/979101 [patent_app_country] => US [patent_app_date] => 2000-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10344 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235521.pdf [firstpage_image] =>[orig_patent_app_number] => 09979101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209640 [patent_doc_number] => 06713444 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins' [patent_app_type] => B1 [patent_app_number] => 09/570023 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 11470 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713444.pdf [firstpage_image] =>[orig_patent_app_number] => 09570023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373050 [patent_doc_number] => 06562784 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals' [patent_app_type] => B1 [patent_app_number] => 09/568142 [patent_app_country] => US [patent_app_date] => 2000-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7581 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562784.pdf [firstpage_image] =>[orig_patent_app_number] => 09568142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278476 [patent_doc_number] => 06645934 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Peptide with radio protective effect' [patent_app_type] => B1 [patent_app_number] => 09/485874 [patent_app_country] => US [patent_app_date] => 2000-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6642 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645934.pdf [firstpage_image] =>[orig_patent_app_number] => 09485874 [rel_patent_id] =>[rel_patent_doc_number] =>)